X

Thank you for sharing!

Your article was successfully shared with the contacts you provided.
Photo: joker1991/Shutterstock.com

A shareholder has accused pharmaceutical company MEI Pharma Inc. of inflating stock prices by overhyping the trial success of a blood cancer treatment.

This premium content is locked for
Delaware Business Court Insider subscribers only.

Already have an account?
Interested in customizing your subscription with Law.com access?
Contact our Sales Professionals at 1-855-808-4530 or send an email
to [email protected] to learn more.

Ellen Bardash

Law Firms Mentioned

 
 

ALM Legal Publication Newsletters

Sign Up Today and Never Miss Another Story.

As part of your digital membership, you can sign up for an unlimited number of a wide range of complimentary newsletters. Visit your My Account page to make your selections. Get the timely legal news and critical analysis you cannot afford to miss. Tailored just for you. In your inbox. Every day.

Copyright © 2020 ALM Media Properties, LLC. All Rights Reserved.